InvestorsHub Logo
Followers 139
Posts 23250
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Tuesday, 05/10/2022 11:29:09 AM

Tuesday, May 10, 2022 11:29:09 AM

Post# of 463623
Top-line results from the randomized, placebo-controlled Phase 2b/3 study ANAVEX®2-73-AD-004 for the treatment of Alzheimer’s disease are expected 2H 2022.

Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News